Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinhu Qingwen Granule for Viral Pneumonia
NCT04955223Phase 1Unknown
- Start
- Dec 2022
- Primary completion
- Dec 2024
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Yinhu Qingwen Granula in viral pneumonia. Primary endpoint: Time to the normalization of the temperature up to 30 days. Status: unknown.
02
Drugs
Yinhu Qingwen Granula
03
Conditions
viral pneumonia
Beyond the preview
Go deeper on NCT04955223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04955223.